霸王茶姬再陷咖啡因含量争议

Core Viewpoint - Bawang Chaji is facing public scrutiny due to concerns over caffeine content in its beverages, leading to significant stock price fluctuations and legal responses from the company [2][4]. Group 1: Caffeine Controversy - A social media post claimed that high-caffeine drinks like Bawang Chaji's are akin to "quasi-drugs," sparking widespread discussion and complaints from consumers about insomnia and palpitations after consumption [2]. - Bawang Chaji responded by stating that the claims are malicious fabrications damaging to its reputation, and legal action has been initiated [2]. - Despite the company's response, its stock fell over 14% on December 26, marking the largest single-day drop since its IPO [2]. Group 2: Product Information - The caffeine content in Bawang Chaji's products varies, with a 580ml "Boya Jue Xuan" containing approximately 117.2 mg of caffeine, while the "Wanjie Mulan" drink has about 184.4 mg [3]. - To cater to consumer demand, Bawang Chaji launched low-caffeine versions of popular drinks in March and May, reducing caffeine content by about 50% compared to regular versions [3]. - The company has added warnings on its app, advising consumers to consider their own tolerance to caffeine when consuming its products [3]. Group 3: Market Impact - As of December 26, Bawang Chaji's stock price closed at $11.9 per share, down over 60% from its listing price on April 17 [4].